Pls Refer the Attachment
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vijaya Diagnostic Centre's Board approved audited standalone and consolidated financial results for Q4 and FY ended March 2026. The Board recommended a final dividend of ₹2 per share (200% on ₹1 face value), subject to shareholder approval at the AGM. Dr. D Nageshwar Reddy will not seek re-appointment for a second term as Independent Director due to pre-occupation and other professional commitments. The company granted 1,79,500 ESOPs at ₹784 per option (average price with 20% discount) to eligible employees under VDCL ESOP Plan 2018. Additionally, the company approved acquisition of MRI, EEG and NCV Services Business from its wholly-owned subsidiary Medinova Millennium MRI Services LLP for approximately ₹4.20 crore in cash. This acquisition is classified as a Related Party Transaction.
The dividend declaration and ESOP grants are positive signals for shareholders and employee retention. The related party acquisition from a wholly-owned subsidiary streamlines the business structure. The departure of Dr. D Nageshwar Reddy removes a key independent director from the board.